Thank you again, Mr. Chair.
I want to follow up on my earlier line of questioning with Dr. Sharma and then with Dr. Zuckerman.
Regarding the process that's in place, Dr. Sharma, what can we expect to see as the next step in all this? How does Health Canada move from its consideration of scientific and other evidence to a regulatory policy decision on this device? Where are we, and what are the next steps? Can you give us a timeframe?